Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment

Description

This study evaluates the feasibility and accuracy of using saliva to remotely monitor cytomegalovirus (CMV) infection in individuals receiving treatment for ovarian cancer.

Conditions

Cancer-related Cognitive Dysfunction, Cytomegaloviral Infection, Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma

Talk to us

Study Overview

On this page

Study Details

Study overview

This study evaluates the feasibility and accuracy of using saliva to remotely monitor cytomegalovirus (CMV) infection in individuals receiving treatment for ovarian cancer.

Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment

Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment

Condition
Cancer-related Cognitive Dysfunction
Intervention / Treatment

-

Contacts and Locations

Minneapolis

University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States, 55455

Rochester

Mayo Clinic in Rochester, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age ≥ 18
  • * Ability to read and write in English
  • * Diagnosed with ovarian cancer (ovarian, primary peritoneal, fallopian tube)
  • * Receiving care from providers at Mayo Clinic
  • * Regardless of diseases status, actively receiving treatment for ovarian cancer (frontline, maintenance, progression, recurrence)
  • * Pregnant at the time of study participation
  • * Inability to provide informed written consent
  • * History of dementia, stroke, brain tumors or other condition which may impair cognitive functioning

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

Amanika Kumar, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic in Rochester

Study Record Dates

2026-03-03